Ximelagatran: an eulogy.
Boos
Christopher J
CJ
Lip
Gregory Y H
GY
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001384:Azetidines / Q000009:adverse effects* / Q000627:therapeutic use*; D001596:Benzylamines / Q000009:adverse effects* / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D017277:Drug Approval; D006801:Humans; D008099:Liver / Q000187:drug effects*; D018570:Risk Assessment; D013923:Thromboembolism / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran